Treatment of brain metastases: Review of phase III randomized controlled trials
Open Access
- 29 February 2012
- journal article
- review article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 102 (2), 168-179
- https://doi.org/10.1016/j.radonc.2011.08.041
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Why avoid the hippocampus? A comprehensive reviewRadiotherapy and Oncology, 2010
- Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933Radiotherapy and Oncology, 2010
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancerBritish Journal of Cancer, 2009
- Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trialJournal of Neuro-Oncology, 2007
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Postoperative Radiotherapy in the Treatment of Single Metastases to the BrainJAMA, 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgeryAnnals of Neurology, 1993
- The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1980